Literature DB >> 9291908

Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?

J Y Lallemand, V Stoven, J P Annereau, J Boucher, S Blanquet, J Barthe, G Lenoir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9291908     DOI： 10.1016/s0140-6736(05)63510-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Macrolides in the respiratory tract in cystic fibrosis.

Authors:  Adam Jaffé; Mark Rosenthal
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Substrates of multidrug resistance-associated proteins block the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  P Linsdell; J W Hanrahan
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 3.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

5.  Adenosine triphosphate-dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  P Linsdell; J W Hanrahan
Journal:  J Gen Physiol       Date:  1998-04       Impact factor: 4.086

Review 6.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

Review 7.  Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?

Authors:  V Witko-Sarsat; I Sermet-Gaudelus; G Lenoir; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

8.  Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.

Authors:  I Sermet-Gaudelus; V Stoven; J P Annereau; V Witko-Sarsat; P Reinert; M Guyot; B Descamps-Latscha; J Y Lallemand; G Lenoir
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

9.  The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis.

Authors:  Elena Nicolis; Matteo Pasetto; Cristina Cigana; Ugo Pradal; Baroukh M Assael; Paola Melotti
Journal:  BMC Med Genet       Date:  2006-02-07       Impact factor: 2.103

10.  Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.

Authors:  Zhichao Liu; Jürgen Borlak; Weida Tong
Journal:  Genome Med       Date:  2014-12-02       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.